Core signature genes for EMT, matrix remodeling processes, and TGF-β were mostly significantly upregulated in RNAMethyPro-identified high-risk patients in all GI cancers (except PDAC) and lung adenocarcinoma (LUAD; Fig. 2c). The gene discussed is TGFB1; the disease is lung adenocarcinoma.